HU175142B - Process for producing insulin composition of prolonged activity, with weak antigenic effectivity - Google Patents

Process for producing insulin composition of prolonged activity, with weak antigenic effectivity

Info

Publication number
HU175142B
HU175142B HU76NO198A HUNO000198A HU175142B HU 175142 B HU175142 B HU 175142B HU 76NO198 A HU76NO198 A HU 76NO198A HU NO000198 A HUNO000198 A HU NO000198A HU 175142 B HU175142 B HU 175142B
Authority
HU
Hungary
Prior art keywords
effectivity
insulin composition
producing insulin
prolonged activity
weak antigenic
Prior art date
Application number
HU76NO198A
Other languages
Hungarian (hu)
Inventor
Bruno A Hansen
Finn H Andresen
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Publication of HU175142B publication Critical patent/HU175142B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • C07K14/625Extraction from natural sources
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HU76NO198A 1975-01-15 1976-01-15 Process for producing insulin composition of prolonged activity, with weak antigenic effectivity HU175142B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK8375AA DK140801B (en) 1975-01-15 1975-01-15 Process for the preparation of a stable long-acting insulin preparation.

Publications (1)

Publication Number Publication Date
HU175142B true HU175142B (en) 1980-05-28

Family

ID=8089535

Family Applications (1)

Application Number Title Priority Date Filing Date
HU76NO198A HU175142B (en) 1975-01-15 1976-01-15 Process for producing insulin composition of prolonged activity, with weak antigenic effectivity

Country Status (36)

Country Link
JP (1) JPS5946939B2 (en)
AR (1) AR213088A1 (en)
AT (1) AT362492B (en)
BE (1) BE837600A (en)
BR (1) BR7600206A (en)
CA (1) CA1094549A (en)
CH (1) CH631625A5 (en)
CS (1) CS208147B2 (en)
DD (1) DD124379A5 (en)
DE (1) DE2600971C2 (en)
DK (1) DK140801B (en)
EG (1) EG11988A (en)
ES (1) ES444558A1 (en)
FI (1) FI66751C (en)
FR (1) FR2297634A1 (en)
GB (1) GB1524431A (en)
GR (1) GR58608B (en)
HU (1) HU175142B (en)
IE (1) IE42395B1 (en)
IL (1) IL48845A (en)
IN (1) IN143279B (en)
IT (1) IT1054211B (en)
KE (1) KE2919A (en)
LU (1) LU74175A1 (en)
MX (1) MX4052E (en)
MY (1) MY7900169A (en)
NL (1) NL166464C (en)
NO (1) NO146698C (en)
NZ (1) NZ179733A (en)
OA (1) OA05209A (en)
PL (1) PL99927B1 (en)
PT (1) PT64696B (en)
RO (1) RO71576A (en)
SE (1) SE437219B (en)
YU (1) YU8376A (en)
ZA (1) ZA7658B (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK374579A (en) * 1979-09-07 1981-03-08 Nordisk Insulinlab PROCEDURE FOR THE PREPARATION OF AN INJUCABLE INSULIN PREPARATION
US4459226A (en) * 1982-02-26 1984-07-10 Eli Lilly And Company Process for recovering insulin
US4801575A (en) * 1986-07-30 1989-01-31 The Regents Of The University Of California Chimeric peptides for neuropeptide delivery through the blood-brain barrier
AU609769B2 (en) * 1987-02-10 1991-05-09 Drug Delivery Systems Inc. Electrolytic transdermal delivery of proteins
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
US5447728A (en) 1992-06-15 1995-09-05 Emisphere Technologies, Inc. Desferrioxamine oral delivery system
US5629020A (en) * 1994-04-22 1997-05-13 Emisphere Technologies, Inc. Modified amino acids for drug delivery
US5714167A (en) 1992-06-15 1998-02-03 Emisphere Technologies, Inc. Active agent transport systems
US6221367B1 (en) 1992-06-15 2001-04-24 Emisphere Technologies, Inc. Active agent transport systems
US5643957A (en) 1993-04-22 1997-07-01 Emisphere Technologies, Inc. Compounds and compositions for delivering active agents
US6051258A (en) 1995-06-07 2000-04-18 Emisphere Technologies, Inc. Proteinoid emulsions and methods for preparation and use thereof
US5750147A (en) 1995-06-07 1998-05-12 Emisphere Technologies, Inc. Method of solubilizing and encapsulating itraconazole
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
JP5670421B2 (en) 2009-03-31 2015-02-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Component surface coating method
EP2432531B1 (en) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalation device and nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5715640B2 (en) 2009-11-25 2015-05-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Nebulizer
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
US9943654B2 (en) 2010-06-24 2018-04-17 Boehringer Ingelheim International Gmbh Nebulizer
EP2694220B1 (en) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
ES2836977T3 (en) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizer
PL3139984T3 (en) 2014-05-07 2021-11-08 Boehringer Ingelheim International Gmbh Nebulizer
CN106232166B (en) 2014-05-07 2020-04-14 勃林格殷格翰国际有限公司 Sprayer with a spray tube
CN106255554B (en) 2014-05-07 2021-05-04 勃林格殷格翰国际有限公司 Container, sprayer and use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3758683A (en) * 1971-04-30 1973-09-11 R Jackson Insulin product

Also Published As

Publication number Publication date
RO71576A (en) 1980-12-30
FI66751B (en) 1984-08-31
IL48845A0 (en) 1976-03-31
MX4052E (en) 1981-11-24
LU74175A1 (en) 1977-03-18
DK140801B (en) 1979-11-19
NO760118L (en) 1976-07-16
YU8376A (en) 1982-06-30
AT362492B (en) 1981-05-25
DK8375A (en) 1976-07-16
JPS5946939B2 (en) 1984-11-15
AU1030776A (en) 1977-07-21
SE7600284L (en) 1976-07-16
PT64696B (en) 1977-08-10
NO146698C (en) 1982-11-24
IE42395L (en) 1976-07-15
NO146698B (en) 1982-08-16
FR2297634B1 (en) 1979-03-30
PL99927B1 (en) 1978-08-31
ZA7658B (en) 1976-12-29
DK140801C (en) 1980-04-21
NL166464C (en) 1981-08-17
JPS51125299A (en) 1976-11-01
ATA21376A (en) 1980-10-15
NZ179733A (en) 1978-04-28
IT1054211B (en) 1981-11-10
PT64696A (en) 1976-02-01
OA05209A (en) 1981-02-28
KE2919A (en) 1979-03-30
IL48845A (en) 1981-06-29
NL7600338A (en) 1976-07-19
MY7900169A (en) 1979-12-31
IN143279B (en) 1977-10-29
IE42395B1 (en) 1980-07-30
GR58608B (en) 1977-11-10
DD124379A5 (en) 1977-02-16
FI760058A (en) 1976-07-16
BE837600A (en) 1976-07-15
CH631625A5 (en) 1982-08-31
ES444558A1 (en) 1977-05-16
GB1524431A (en) 1978-09-13
DE2600971A1 (en) 1976-07-22
AR213088A1 (en) 1978-12-15
FR2297634A1 (en) 1976-08-13
FI66751C (en) 1984-12-10
SE437219B (en) 1985-02-18
DE2600971C2 (en) 1985-12-12
NL166464B (en) 1981-03-16
CS208147B2 (en) 1981-08-31
EG11988A (en) 1978-06-30
BR7600206A (en) 1976-08-31
CA1094549A (en) 1981-01-27

Similar Documents

Publication Publication Date Title
HU175142B (en) Process for producing insulin composition of prolonged activity, with weak antigenic effectivity
HU171030B (en) Process for preparing new oxime-ether compounds with antidepressant activity
HU175963B (en) Process for producing biologically active polimers of 3-square bracket-n-comma above-bracket-3-halogeno-propyl-bracket closed-n-comma above-methyl-amino-square bracket closed-n,n,n-trimethyl-1-propanaminium-halogenides
HK52580A (en) 3-amino-indazolecarboxylic acid derivatives,process for their preparation and their use as medicaments
KE3022A (en) Azolyl-(1)-methanes and their salts,process for their preparation and their use as medicaments
EG11983A (en) Substituted phenylguanides,a process for their preparation and their use as medicaments
HU172633B (en) Process for producing thiazolinyl- or 5,6-dihydro-4h-1,3-thiazinyl-benzimidazol-esters of antivirus activity
HU172937B (en) Process for preparing chondroitinsulphuric acid derivatives with local anaesthetic activity
HU172649B (en) Process for producing new, biologically active lysergamides
GR58248B (en) Process for the preparation of i,i,i,triarilo-alcilamines
IL47443A0 (en) Process for the manufacture of insulin,analogs and derivatives thereof
CH613608A5 (en) Process for producing sauce-like preparations
HU170888B (en) Process for producing new, optically active eburnamenine derivatives
GR63123B (en) Preparation process of novel 1,4-diphenyl-3-pyrazolin-5-ones
JPS5234918A (en) Production of gmmaglobulin suitable for dosing into vein
GR60034B (en) New 9-alkylamino-erythromycin,their salts,and process for their preparation
ZA754558B (en) Substituted phenylisothioureas, a process for their preparation and their use as medicaments
IL49160A (en) Preparation of 5-alkyl-1-phenyl-tetrahydro-benz(f)-2,5-oxazocines
EG12328A (en) Process for preparing of substituted 2-phenylimino-1,3-dithiolanes
HU171028B (en) Process for preparing new oxime-ether compounds with antidepressant activity
GR61598B (en) Disubstituted phenolethers of 3-amino-2-hydroxypropan,preparation process thereof and use thereof as medicines
GR60560B (en) Penicillines,preparation process and use thereof as medicines
CS189776B2 (en) Method of producing 5-cyan-4-methyl-1,3-oxazole
PT65713B (en) Process for preparation of cycloalkanapyrazole with effectherbicide
HU171159B (en) Process for preparing new oxyme-ether compounds with antidepressive activity